ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2363 • 2018 ACR/ARHP Annual Meeting

    Examining Workplace Supports in the Context of RA Disease Activity

    W. Benjamin Nowell1, Kelly Gavigan1, Guillermo Ernest Gonzales2, Shilpa Venkatachalam1, Jeffrey R. Curtis3, Sheiva Ghazanfari4, Danielle Cavazzini4 and Leticia Ferri4, 1Global Healthy Living Foundation, Upper Nyack, NY, 2Silver School of Social Work, New York University, New York, NY, 3University of Alabama at Birmingham, Birmingham, AL, 4Bristol-Myers Squibb, Princeton, NJ

    Background/Purpose: RA can diminish patients’ (pts) work productivity and increase the risk of long-term disability, economic insecurity and worsening health, but limited research informs these…
  • Abstract Number: 2364 • 2018 ACR/ARHP Annual Meeting

    Vasculitis Patient Journey: A Scoping Review of Patient Experiences with Vasculitis

    Navjeet Gill and Elaine Yacyshyn, Medicine, University of Alberta, Edmonton, AB, Canada

    Abstract:Background/Purpose: Optimal management of vasculitis needs to address disease aspects of significance to patients. Understanding the patients’ journey with vasculitis allows clinicians to identify patient…
  • Abstract Number: 2365 • 2018 ACR/ARHP Annual Meeting

    Sex, Language and Age of Disease Onset Impact Illness Perceptions Among RA Patients

    Susan J. Bartlett1, Mariana Useche2, Maria Celia Bazan Bardales3, Elizabeth Hazel4 and Ines Colmegna5, 1Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 2Medicine, The Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 3The Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 4Rheumatology, McGill University Health Centre, Pointe-Claire, QC, Canada, 5The Research Institute of the McGill University Health Centre, Division of Rheumatology, Department of Medicine, McGill University, Montreal, Quebec, Canada, Montreal, QC, Canada

    Background/Purpose: Patients’ illness perceptions (IP) influence self-management, adherence, and outcomes. Little is known about how cultural background and the lived experiences influence IP among rheumatoid…
  • Abstract Number: 2366 • 2018 ACR/ARHP Annual Meeting

    Facilitating Shared Decision Making in Psoriatic Arthritis: Factors Influencing Patient Preference for Treatment Mode of Administration

    Daniel Aletaha1, M. Elaine Husni2, Joseph F. Merola3, Roberto Ranza4, Heidi Bertheussen5, Ralph Lippe6, Pamela Young7, Joseph C Cappelleri8, T Michelle Brown9, Claire Ervin9, Ming-Ann Hsu8 and Lara Fallon10, 1Medical University of Vienna, Vienna, Austria, 2Cleveland Clinic, Orthopedic and Rheumatologic Institute, Cleveland, OH, 3Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 4Servicio de Reumatología, Universidade Federal de Uberlandia, Santa Mônica, Uberlândia, Brazil, 5Patient Representative, Oslo, Norway, 6Pfizer Pharma GmbH, Berlin, Germany, 7Pfizer Inc, Collegeville, PA, 8Pfizer Inc, Groton, CT, 9RTI Health Solutions, Research Triangle Park, NC, 10Pfizer Canada, Montreal, QC, Canada

    Background/Purpose: Shared decision making is key to optimizing management of patients (pts) with psoriatic arthritis (PsA).1 Few studies have evaluated pt preferences for treatment administration…
  • Abstract Number: 2367 • 2018 ACR/ARHP Annual Meeting

    Acceptance Rate and Sociological Factors Involved in the Switch from Originator to Biosimilar Etanercept (SB4)

    Marc Scherlinger1,2,3, Vincent Germain1, Emmanuel Langlois4 and Thierry Schaeverbeke5, 1Department of Rheumatology, Bordeaux University Hospital, Bordeaux, France, 2FHU ACRONIM, Bordeaux, France, 3Rheumatology, UMR CNRS 5164 - Immunoconcept, France, Bordeaux, France, 4CNRS-UMR 5116 Centre Emile Durkheim, Bordeaux, France, 5Department of Rheumatology, Bordeaux University Hospital, BORDEAUX, France

    Background/Purpose: Biosimilars represent major potential savings while preserving treatment quality. However, few data are known on how to address the switch from originator to biosimilar…
  • Abstract Number: 2368 • 2018 ACR/ARHP Annual Meeting

    Patient Preferences for Disease Modifying Anti-Rheumatic Drug Treatment in Rheumatoid Arthritis: A Systematic Review

    Caylib Durand1, Maysoon Eldoma1, Deborah A. Marshall2 and Glen Hazlewood1,3, 1Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 2Community Health Sciences, University of Calgary, Calgary, AB, Canada, 3Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada

    Background/Purpose: Treatment choices in rheumatoid arthritis (RA) involve trade-offs in risks, benefits and other considerations such as dosing. Understanding patient preferences for these trade-offs is…
  • Abstract Number: 2369 • 2018 ACR/ARHP Annual Meeting

    Patients Preference Goes to MTX Autoinjectors over Prefilled Syringes: Results from a Phase III Trial

    Alain Saraux1, Christophe Hudry2, Elena Zinovieva3, Agnès Courbeyrette4 and Hélène Herman-Demars3, 1Rheumatology, CHU Brest, Brest, France, 2AP-HP Hôpital Cochin, Paris, France, 3Medical Department Nordic Pharma, Paris, France, 4Medical Departement, Nordic Pharma, Paris, France

    Background/Purpose: The offer of injectable MTX worldwide expanded during past few years with different types of enhanced devices such as prefilled syringes and autoinjector pens.…
  • Abstract Number: 2370 • 2018 ACR/ARHP Annual Meeting

    Physician and Patient Preferences for Treating SLE: Insights into the Choice of Intravenous Infusion and Subcutaneous Injection

    Matthew Lau1, Christopher F Bell1, Christine Poulos2 and Ameya Benegal3, 1GlaxoSmithKline, Research Triangle Park, NC, 2RTI Health Solutions, Research Triangle Park, NC, 3RTI Health Solutions, RTP, NC

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease characterized by diverse clinical manifestations, chronic inflammation, and significant morbidity that can be fatal1.…
  • Abstract Number: 2371 • 2018 ACR/ARHP Annual Meeting

    Use of Social Media Among Patients with Rheumatic Diseases

    Mustafa Erdogan1, Okan Aydin2 and Emire Seyahi1, 1Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, 2Internal Medicine, Divison of Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, İstanbul, Turkey

     Background/Purpose: The impact of social media on individual or institutional communication and knowledge acquisition is non-negligible. Whether patients (pts) with rheumatic diseases share information about…
  • Abstract Number: 2372 • 2018 ACR/ARHP Annual Meeting

    Social Media Use for Health-Related Purposes By People with Rheumatic and Musculoskeletal Diseases – Results of a Global Survey

    Paul Studenic1, Alessia Alunno2, Simon R Stones3, Valentin Ritschl4 and Elena Nikiphorou5, 1Division of Rheumatology, Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 2Department of Medicine, Rheumatology Unit, University of Perugia, Perugia, Italy, 3School of Healthcare, University of Leeds, Leeds, United Kingdom, 4Center for Medical Statistics, Informatics, and Intelligent Systems, Section for Outcomes Research, Medical University of Vienna, Vienna, Austria, Vienna, Austria, 5Academic Rheumatology, Department of Inflammation Biology, King's College London, London, Great Britain

    Background/Purpose: Smartphone applications and social media (SM) are increasingly used, transforming the way in which people communicate. Peer interaction, remote information access and community building…
  • Abstract Number: 2373 • 2018 ACR/ARHP Annual Meeting

    How Do Patients Describe Their “New Normal” in Systemic Lupus Erythematosus? Use of Probabilistic Topic Modelling to Characterize Patients’ Experiences Recorded in an Online Health Community

    Stephanie Eaneff1, Timothy Vaughan1, Volkan Barut2, Jesper Havsol3, Brad Nohe4 and Cathy Emmas5, 1PatientsLikeMe, Boston, MA, 2Global Medical Affairs, AstraZeneca, Cambridge, United Kingdom, 3Advanced Analytics Centre, AstraZeneca, Gothenburg, Sweden, 4AstraZeneca, Gaithersburg, MD, 5Patient Centricity, AstraZeneca, Cambridge, United Kingdom

    Background/Purpose: Patients living with systemic lupus erythematosus (SLE) must typically adapt to altered quality of life and tailor coping mechanisms (e.g. non-pharmacological interventions) to address…
  • Abstract Number: 2374 • 2018 ACR/ARHP Annual Meeting

    Flare Warnings: People with Rheumatoid Arthritis’ Perceptions of Their Flares

    Nancy A. Baker1, Laurel Person Mecca2 and Sara R. Piva3, 1Department of Occupational Therapy, Tufts University, Medford, MA, 2University of Pittsburgh, Pittsburgh, PA, 3Physical Therapy, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Flares are exacerbations of rheumatoid arthritis (RA) symptoms of sufficient intensity to require some change in treatment. Even when well-managed, more than half of…
  • Abstract Number: 2375 • 2018 ACR/ARHP Annual Meeting

    When Are People Receptive to Self Management Education Information, and What Information Appeals to Them? : An Analysis of Digital Data

    Teresa Brady1, Meghan Lewis2 and Carla Cartwright2, 1Clarity Consulting and Communications, Atlanta, GA, 2Porter Novelli, Atlanta, GA

    Background/Purpose:   CDC pilot-tested a marketing campaign to promote self-management education (SME) as a chronic disease management strategy.  The campaign targets adults ages 45-75 with…
  • Abstract Number: 2376 • 2018 ACR/ARHP Annual Meeting

    Something for Us: Client Perspectives on Lupus Self-Management Programming Using the 5-a Behavior Change Model

    Brenda L Frie, Occupational Therapy Dept., St. Catherine University, St. Paul, MN

    Background/Purpose: Systemic lupus erythematosus is the most common and most severe form of lupus involving multiple body systems including the blood, muscles, joints, organs and…
  • Abstract Number: 2377 • 2018 ACR/ARHP Annual Meeting

    Body Image in Rheumatic Diseases: A Systematic Review

    Shadi Gholizadeh1, Annie Meier2, Sarah D. Mills3 and Vanessa L. Malcarne4, 1Clinical Psychology, SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA, 2Psychology, San Diego State University, San Diego, CA, 3Medicine, Lineberger Comprehensive Cancer Center University of North Carolina, Durham, NC, 4SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego, CA

    Background/Purpose: In health conditions that cause changes in appearance, especially in areas of the body that are highly visible and socially salient (e.g., face and…
  • « Previous Page
  • 1
  • …
  • 1160
  • 1161
  • 1162
  • 1163
  • 1164
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology